Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DXCM · against 1,216 other Healthcare companies
Ranked #263 of 1,217 · scores higher than 78% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including DXCM · Click a bar to see the companies
Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | DXCM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 15.5% | 6.1% | 72% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 81.8% | 9.7% | 84% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 15.8% | 5.8% | 75% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 263 | 1.8B USD | 78 | 63 | |
| 263 | 457M USD | 78 | 58 | |
| 263 | 326M EUR (≈$359M) | 78 | 75 | |
| 263 | 8.7B USD | 78 | 26 | |
| 263 | 31.3B USD | 78 | 63 | |
| 263 | 27.5B EUR (≈$30.2B) | 78 | 60 | |
| 263 | 549M EUR (≈$604M) | 78 | 56 | |
| 263 | 126.5B USD | 78 | 56 | |
| 263 | 1.1B USD | 78 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score